TrialCNS drugs2025

Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).

Yi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.